Coherus Biosciences Stock Market Value
| CHRS Stock | USD 1.26 0.02 1.56% |
| Symbol | Coherus |
Coherus BioSciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coherus BioSciences. If investors know Coherus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coherus BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.09) | Revenue Per Share 2.678 | Quarterly Revenue Growth (0.05) | Return On Assets (0.14) |
The market value of Coherus BioSciences is measured differently than its book value, which is the value of Coherus that is recorded on the company's balance sheet. Investors also form their own opinion of Coherus BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Coherus BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coherus BioSciences' market value can be influenced by many factors that don't directly affect Coherus BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coherus BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Coherus BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coherus BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coherus BioSciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Coherus BioSciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Coherus BioSciences.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Coherus BioSciences on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Coherus BioSciences or generate 0.0% return on investment in Coherus BioSciences over 30 days. Coherus BioSciences is related to or competes with Assembly Biosciences, Spero Therapeutics, Achilles Therapeutics, Instil Bio, NextCure, Nuvation Bio, and CytomX Therapeutics. Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily i... More
Coherus BioSciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Coherus BioSciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Coherus BioSciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.06 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 35.06 | |||
| Value At Risk | (6.94) | |||
| Potential Upside | 8.96 |
Coherus BioSciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Coherus BioSciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Coherus BioSciences' standard deviation. In reality, there are many statistical measures that can use Coherus BioSciences historical prices to predict the future Coherus BioSciences' volatility.| Risk Adjusted Performance | 0.0146 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.95) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0483 |
Coherus BioSciences Backtested Returns
Currently, Coherus BioSciences is very risky. Coherus BioSciences secures Sharpe Ratio (or Efficiency) of 0.0126, which signifies that the company had a 0.0126% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Coherus BioSciences, which you can use to evaluate the volatility of the firm. Please confirm Coherus BioSciences' Mean Deviation of 4.12, downside deviation of 5.06, and Risk Adjusted Performance of 0.0146 to double-check if the risk estimate we provide is consistent with the expected return of 0.0837%. The firm shows a Beta (market volatility) of 0.81, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Coherus BioSciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Coherus BioSciences is expected to be smaller as well. Coherus BioSciences right now shows a risk of 6.67%. Please confirm Coherus BioSciences skewness, day median price, as well as the relationship between the value at risk and jensen alpha , to decide if Coherus BioSciences will be following its price patterns.
Auto-correlation | 0.63 |
Good predictability
Coherus BioSciences has good predictability. Overlapping area represents the amount of predictability between Coherus BioSciences time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Coherus BioSciences price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Coherus BioSciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Coherus BioSciences lagged returns against current returns
Autocorrelation, which is Coherus BioSciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Coherus BioSciences' stock expected returns. We can calculate the autocorrelation of Coherus BioSciences returns to help us make a trade decision. For example, suppose you find that Coherus BioSciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Coherus BioSciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Coherus BioSciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Coherus BioSciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Coherus BioSciences stock over time.
Current vs Lagged Prices |
| Timeline |
Coherus BioSciences Lagged Returns
When evaluating Coherus BioSciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Coherus BioSciences stock have on its future price. Coherus BioSciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Coherus BioSciences autocorrelation shows the relationship between Coherus BioSciences stock current value and its past values and can show if there is a momentum factor associated with investing in Coherus BioSciences.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.